I recently shared my perspective on President Trump’s newest executive order, which is designed to restrict federal contractors from participating in what the administration characterizes as “racially discriminatory” DEI efforts. Under this order, certain DEI‑related activities could put a contractor’s eligibility for future federal work at risk.Continue Reading Understanding the False Claims Act Implications of Trump’s Latest DEI Order for Federal Contractors
Genetic Testing Fraud: Why CMS and DOJ Are Increasing Scrutiny
In 2025, the Department of Justice’s National Health Care Fraud Takedown led to criminal charges against 324 defendants and $14.6 billion in intended losses. Continue Reading Genetic Testing Fraud: Why CMS and DOJ Are Increasing Scrutiny
Download Now | 14th Annual Healthcare Fraud & Abuse Review
Ensuring compliance with the False Claims Act has never been more important for healthcare providers.
Bass, Berry & Sims is pleased to announce the release of the 14th annual Healthcare Fraud & Abuse Review examining important healthcare fraud developments in 2025. Continue Reading Download Now | 14th Annual Healthcare Fraud & Abuse Review
DOJ Releases Record-Setting Civil Fraud Recovery Statistics and Results…Our Annual Look Behind the Numbers
On January 16, the U.S. Department of Justice (DOJ) released its annual report on civil fraud recoveries (settlements and judgments) for FY2025, along with a press release highlighting DOJ’s civil enforcement efforts. Continue Reading DOJ Releases Record-Setting Civil Fraud Recovery Statistics and Results…Our Annual Look Behind the Numbers
Kaiser Permanente Affiliates Settle Medicare Risk Adjustment Fraud Case for $556 Million
On January 14, the Department of Justice (DOJ) announced that five Kaiser Permanente affiliates agreed to pay $556 million to resolve allegations that they violated the False Claims Act (FCA) by submitting unsupported diagnosis codes for Medicare Advantage (MA) beneficiaries to increase reimbursement from the federal government. The relators will receive approximately $95 million as their share of the recovery.Continue Reading Kaiser Permanente Affiliates Settle Medicare Risk Adjustment Fraud Case for $556 Million
HHS-OIG’s Latest Wound Care Report Warrants Careful Scrutiny
On September 9, the U.S. Department of Health and Human Services Office of the Inspector General (HHS-OIG) released a major report (Report) regarding the fraud risks currently associated with skin substitute products billed to Medicare.Continue Reading HHS-OIG’s Latest Wound Care Report Warrants Careful Scrutiny
Cracking Down on Customs Fraud: How the False Claims Act Raises the Stakes for Importers
The federal government’s growing use of the False Claims Act (FCA) to pursue customs fraud signals a new era of trade enforcement, with importers facing heightened scrutiny and increased risk of whistleblower actions. Continue Reading Cracking Down on Customs Fraud: How the False Claims Act Raises the Stakes for Importers
Rare (c)(2)(A) Dismissal of Long-Running FCA Case
We were quoted in a Law360 article summarizing a September 2025 decision by a Utah federal court to dismiss False Claims Act (FCA) allegations against our clients. Continue Reading Rare (c)(2)(A) Dismissal of Long-Running FCA Case
False Claims Act Settlements to Know from the First Half of 2025
With the first half of 2025 in the rearview mirror, the government’s continued focus on False Claims Act (FCA) enforcement shows no signs of slowing. In fact, the Department of Justice recently announced the results of a record-setting National Health Care Fraud Takedown, which resulted in criminal charges against 324 defendants for alleged healthcare fraud schemes involving over $14.6 billion.Continue Reading False Claims Act Settlements to Know from the First Half of 2025
Wound Care in the Crosshairs: Reimbursements Risks Amid Skin Substitute Fraud Investigations
Effective wound care is critical for patients recovering from surgery or managing chronic or non-healing wounds. Advances in treatment have led to the development of skin substitutes—bioengineered or natural materials designed to promote healing by replacing or supporting damaged skin. While these innovations hold great promise for the future of wound care, they have also come under increased scrutiny by regulatory agencies and the Department of Justice (DOJ).Continue Reading Wound Care in the Crosshairs: Reimbursements Risks Amid Skin Substitute Fraud Investigations